EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

66 hedge funds and large institutions have $248M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+21
Holders Change %
+46.67%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
14
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
1
Eagle Asset Management
Florida
$43.2M
2
FCM
2
Frontier Capital Management
Massachusetts
$7.62M
3
EAM
3
EverPoint Asset Management
Connecticut
$5.86M
4
BFA
4
BlackRock Fund Advisors
California
$5.7M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$21.6M

Top Sellers

1
TCM
1
Tekla Capital Management
Massachusetts
$11.8M
2
MAM
2
MPM Asset Management
Massachusetts
$15.6M
3
VAM
3
Visium Asset Management
New York
$0
4
PHS
4
PFM Health Sciences
California
$8.92M
5
Axa
5
Axa
France
$3.94M
Name Holding Trade Value Shares
Change 		Shares
Change %
PTC
76
Private Trust Company
Ohio
– -$1K – –
TRCT
77
Tower Research Capital (TRC)
New York
– -$1K – –
1 2 3
4